Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5406 Target Snapshot

Histone-arginine methyltransferase CARM1 · SINGLE PROTEIN · Homo sapiens

566Compounds
336Assays
0Approved Drugs
501.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q86X55. Use UniProt Q86X55 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q86X55 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histone-arginine methyltransferase CARM1 as ChEMBL target CHEMBL5406, mapped to UniProt Q86X55. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histone-arginine methyltransferase CARM1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL5406
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q86X55
Histone-arginine methyltransferase CARM1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histone-arginine methyltransferase CARM1 is the right protein anchor across sources, using UniProt Q86X55 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistone-arginine methyltransferase CARM1
UniProt AccessionQ86X55
Component TypeProtein
Sequence Length608 aa

Histone-arginine methyltransferase CARM1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histone-arginine methyltransferase CARM1, mapped to UniProt Q86X55. Sequence length is 608 aa.

Mapped IDQ86X55
Review nameHistone-arginine methyltransferase CARM1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

3
Phase II
Assay Mix

Activity Type Distribution

IC50462.0
KI17.0
EC501.0
KD21.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4436627 10.3 IC50 0.05 Preclinical
CHEMBL584335 10.15 IC50 0.07 Preclinical
CHEMBL571829 9.92 IC50 0.12 Preclinical
CHEMBL571639 9.59 IC50 0.26 Preclinical
CHEMBL572103 9.39 IC50 0.41 Preclinical
CHEMBL5272699 9.19 IC50 0.65 Preclinical
CHEMBL571431 9.15 IC50 0.7 Preclinical
CHEMBL5270700 9.11 IC50 0.78 Preclinical
CHEMBL572102 9.08 IC50 0.84 Preclinical
CHEMBL5274219 9.04 IC50 0.92 Preclinical
Distribution

pChEMBL Value Distribution

28
5.0
47
5.5
46
6.0
46
6.5
72
7.0
70
7.5
37
8.0
18
8.5
6
9.0
2
9.5
pChEMBL
Assay Landscape

Assay Landscape

336
Total Assays
343
Tested Compounds
2
Assay Types
Binding — 328 assays, 343 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 162 68 6.7
single protein format 158 267 6.9
assay format 8 8 4.9
Functional — 8 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 6 4 8.1
cell-based format 2 1 6.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine